- CH₣232.94bn
- CH₣265.12bn
- $56.33bn
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
UBS boss Ermotti's pay stays at $19.1 million in 2025 (updated)
Europe Research Roundup: Airbus, Mercedes-Benz Group, Safestore Holdings
Swiss stocks - Factors to watch on March 6
Brief: Novartis Completes Acquisition Of Avidity Biosciences
Brief: Novartis: European Medicines Agency (EMA) Has Adopted A Positive Opinion Recommending Marketing Authorization For Remibrutinib
Brief: EMA's CHMP Recommended Granting A Marketing Authorisation For Mcombriax
Novartis to build radioligand therapy site in Texas to expand US manufacturing (updated)
Novartis to build radioligand therapy site in Texas to expand US manufacturing
Brief: Novartis Plans To Establish 46,000-Square-Foot Radioligand Therapy Manufacturing Site In Texas
Ethos rejects Novartis CEO, management pay as excessive (updated)
Ethos rejects Novartis CEO, management pay as excessive
Column: Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Swiss stocks - Factors to watch on February 20
Novartis India Ltd surges on $159 million parent stake sale